Insider Stock Trading History of Sandor Victor


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sandor Victor since year 2005. The trader's CIK number is 1620368. At the time of this reporting, Sandor Victor is the Chief Medical Officer of Array Biopharma Inc . (stock ticker symbol ARRY). See this page for all insider trading activities at Array Biopharma Inc .


Stock purchases, sales, and option exercises reported by insider Sandor Victor since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-03 ARRY Array Biopharma Inc Option Ex 127,397 3.65 464,999
2018-12-03 ARRY Array Biopharma Inc Sale 115,185 16.21 1,867,033
2018-09-04 ARRY Array Biopharma Inc Sale 9,687 15.38 148,937
2018-06-27 ARRY Array Biopharma Inc Option Ex 17,440 .00 0
2018-06-19 ARRY Array Biopharma Inc Option Ex 77,576 3.65 283,152
2018-06-19 ARRY Array Biopharma Inc Sale 77,576 18.76 1,455,325
2018-06-13 ARRY Array Biopharma Inc Sale 22,424 18.75 420,450
2018-06-13 ARRY Array Biopharma Inc Option Ex 22,424 3.65 81,847
2018-04-01 ARRY Array Biopharma Inc Option Ex 7,812 .00 0
2018-04-03 ARRY Array Biopharma Inc Sale 8,689 15.35 133,376
2018-03-09 ARRY Array Biopharma Inc Sale 156,016 17.71 2,763,043
2018-03-09 ARRY Array Biopharma Inc Option Ex 182,191 3.65 664,997
2017-12-16 ARRY Array Biopharma Inc Option Ex 11,284 8.79 99,186
2017-04-01 ARRY Array Biopharma Inc Option Ex 7,812 .00 0
2016-09-22 ARRY Array Biopharma Inc Option Ex 95,890 3.69 353,834
2015-09-22 ARRY Array Biopharma Inc Option Ex 95,891 5.18 496,715
2015-03-01 ARRY Array Biopharma Inc Option Ex 17,440 7.96 138,822

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sandor Victor (Chief Medical Officer of Array Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.